Eloxx Pharmaceuticals, Inc. (ELOX)
Market Open
11 Sep, 14:06
NASDAQ (CM) NASDAQ (CM) Primary NASDAQ $
16. 57
+0.29
+1.812%
$
51.54M Market Cap
- P/E Ratio
- Div Yield
1,761 Volume
0 Eps
$ 16.28
Previous Close 
Want to track ELOX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Eloxx Pharmaceuticals, Inc. (ELOX) Statistics
Valuation metrics
Market Cap 51.54M
Enterprise value -10.42M
Trailing P/E (ttm) -9.87
Forward P/E -
PEG ratio -0.11
Price/Sales (ttm) -
Price/Book (mrq) 2.19
Enterprise Value/Revenue -
Enterprise Value/EBITDA 1.27
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 45.8K
Average volume (90 days) 48.82K
Price summary
52-Week low 8.2
52-Week high 23.4
Beta -
50-Day moving average 14.4
200-Day moving average 4.17
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:11
Last split Date 1 Jun 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.13%
Return on equity -0.43%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.22
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 9.13
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 3.74%
Book value per share (mrq) 6.84
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
